These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1113920)

  • 1. [Demonstration of 2 experimental models of pure chronic erythroblastopenia].
    Genovese A; Marone G; Buccelli C; Peschle C
    Minerva Med; 1975 Jan; 66(5):203-8. PubMed ID: 1113920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
    Woodburn KW; Fan Q; Winslow S; Chen MJ; Mortensen RB; Casadevall N; Stead RB; Schatz PJ
    Exp Hematol; 2007 Aug; 35(8):1201-8. PubMed ID: 17662888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure red cell aplasia (PRCA): Response of three patients of cyclophosphamide and/or antilymphocyte globulin (ALG) and demonstration of two types of serum IgG inhibitors to erythropoiesis.
    Marmont A; Peschle C; Sanguineti M; Condorelli M
    Blood; 1975 Feb; 45(2):247-61. PubMed ID: 1078982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pure red cell aplasia.
    Mehzad M; Shafa G; Noury M
    Pahlavi Med J; 1976 Jul; 7(3):397-406. PubMed ID: 787896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proliferative capacity of pure red cell aplasia bone marrow cells.
    Katz LJ; Hoffman R; Ritchey AK; Dainiak N
    Yale J Biol Med; 1981; 54(2):89-94. PubMed ID: 7269642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for reduced erythroid burst (BFUE) promoting function of T lymphocytes in the pure red cell aplasia of chronic lymphocytic leukemia.
    Mangan KF; Chikkappa G; Scharfman WB; Desforges JF
    Exp Hematol; 1981 May; 9(5):489-98. PubMed ID: 6972322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is antibody-mediated pure red cell aplasia (PRCA)?
    Casadevall N
    Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv3-8. PubMed ID: 15827056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pure red cell aplasia: studies on an IgG serum inhibitor neutralizing erythropoietin.
    Peschle C; Marmont AM; Marone G; Genovese A; Sasso GF; Condorelli M
    Br J Haematol; 1975 Aug; 30(4):411-7. PubMed ID: 1201224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure red cell aplasia secondary to treatment with erythropoietin.
    Locatelli F; Del Vecchio L
    J Nephrol; 2003; 16(4):461-6. PubMed ID: 14696747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pure red cell aplasia associated with thymoma. Demonstration of an autoimmune serum factor inhibiting erythropoiesis and remission induced by cyclophosphamide].
    Peschle C; Condorelli M
    Haematologica; 1972; 58(9):553-9. PubMed ID: 4206229
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoimmune disease and chronic lymphocytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia.
    Diehl LF; Ketchum LH
    Semin Oncol; 1998 Feb; 25(1):80-97. PubMed ID: 9482530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Burst-promoting activity (BPA) without erythropoietin (Ep) activity in sera of aplastic anemia patients fractionated by chromatofocusing column.
    Okamoto T; Kanamaru A; Hara H; Nagai K
    Exp Hematol; 1982 Nov; 10(10):844-51. PubMed ID: 7151897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relapsing pure red cell aplasia associated with B-cell chronic lymphocytic leukemia successfully treated by intravenous immunoglobulin concentrate.
    Castelli R; Vismara A; Pavia G; Dagani R; Porro T
    Ann Ital Med Int; 2002; 17(1):47-50. PubMed ID: 11975114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-mediated pure red cell aplasia due to epoetin alfa during antiviral therapy of chronic hepatitis C.
    Stravitz RT; Chung H; Sterling RK; Luketic VA; Sanyal AJ; Price AS; Purrington A; Shiffman ML
    Am J Gastroenterol; 2005 Jun; 100(6):1415-9. PubMed ID: 15929778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic mechanisms of EPO-associated pure red cell aplasia.
    Schellekens H
    Best Pract Res Clin Haematol; 2005; 18(3):473-80. PubMed ID: 15792922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of two distinct antibodies in autoimmune hemolytic anemia with reticulocytopenia and red cell aplasia.
    Mangan KF; Besa EC; Shadduck RK; Tedrow H; Ray PK
    Exp Hematol; 1984 Nov; 12(10):788-93. PubMed ID: 6439569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of biologic follow-ons: experience with EPO.
    Casadevall N; Rossert J
    Best Pract Res Clin Haematol; 2005; 18(3):381-7. PubMed ID: 15792912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic aspects of aplasia.
    Speck B; Cornu P; Sartorius J; Nissen C; Groff P; Burri HP; Jeannet M
    Transplant Proc; 1978 Mar; 10(1):131-4. PubMed ID: 345551
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical characteristics of erythropoietin-associated pure red cell aplasia.
    Carson KR; Evens AM; Bennett CL; Luminari S
    Best Pract Res Clin Haematol; 2005; 18(3):467-72. PubMed ID: 15792921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pure red blood cell aplasia associated with chronic Epstein-Barr virus infection: evidence for T cell-mediated suppression of erythroid colony forming units.
    Socinski MA; Ershler WB; Tosato G; Blaese RM
    J Lab Clin Med; 1984 Dec; 104(6):995-1006. PubMed ID: 6094693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.